de Graaf, H <br/><br/>
Dose intensity of standard adjuvant CMF with granulocyte colony-stimulating factor for premenopausal patients with node-positive breast cancer.  [electronic resource] 

 -  Oncology   
 - 289-94 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0030-2414 
<br/><br/><label>Standard No.: </label>10.1159/000227575  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--blood<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fluorouracil--administration & dosage<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Leukocyte Count--drug effects<br/>Lymphatic Metastasis<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Platelet Count--drug effects<br/>Premenopause